{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Apoptosis", "HeLa cells", "Inflammatory factor", "NF-\u03baB", "PI3K/Akt/mTOR"]], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "26935715", "DateCompleted": {"Year": "2017", "Month": "02", "Day": "21"}, "DateRevised": {"Year": "2021", "Month": "12", "Day": "04"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "03", "Day": "03"}], "ELocationID": ["10.1007/s00210-016-1217-7"], "Language": ["eng"], "Journal": {"ISSN": "1432-1912", "JournalIssue": {"Volume": "389", "Issue": "6", "PubDate": {"Year": "2016", "Month": "Jun"}}, "Title": "Naunyn-Schmiedeberg's archives of pharmacology", "ISOAbbreviation": "Naunyn Schmiedebergs Arch Pharmacol"}, "ArticleTitle": "Anti-proliferative effect of RCE-4 from Reineckia carnea on human cervical cancer HeLa cells by inhibiting the PI3K/Akt/mTOR signaling pathway and NF-\u03baB activation.", "Pagination": {"StartPage": "573", "EndPage": "584", "MedlinePgn": "573-84"}, "Abstract": {"AbstractText": ["Cervical cancer is the second leading cause of cancer deaths in women worldwide. In recent years, the studies find that inflammation is a critical component of tumor progression, and the ideal therapeutic methods should be aimed at the inflammation reaction triggers. (1\u03b2,3\u03b2,5\u03b2,25S)-spirostan-1,3-diol1-[\u03b1-L-rhamnopyranosyl-(1\u2009\u2192\u20092)-\u03b2-D-xylopyranoside] (RCE-4) was the main active composition of Reineckia carnea (Andr.) Kunth. It significantly induced apoptosis in cervical cancer Caski cells through the mitochondrial pathway in our previous studies; however, its underlying mechanism remains poorly understood. This study aimed to further evaluate the effect of RCE-4 on human cervical cancer HeLa cells. Based on this observation, we investigated the anti-cervical cancer effect of RCE-4 by modulating phosphatidylinositol 3-kinase/protein kinase-B/mammalian target of rapamycin (PI3K/Akt/mTOR) signaling pathway, nuclear factor-kappa B (NF-\u03baB) activation, and inflammation-related key factors in HeLa cells. The results indicated that the HeLa cell was the most sensitive with an IC50 of 7.01\u00a0\u03bcM; RCE-4 significantly promoted the release of cellular lactate dehydrogenase (LDH); increased DNA fragmentation and apoptosis; reduced PI3K, Akt, mTOR, and NF-\u03baBp65 phosphorylation levels; increased the Bax and cleaved poly (ADP-ribose) polymerase (PARP) protein levels; suppressed Bcl-2 protein expression; elevated the Bax/Bcl-2 expression ratio; and decreased the interleukin-1 beta (IL-1\u03b2) and interleukin-6 (IL-6) mRNA expressions in HeLa cells in a concentration-dependent manner. These findings suggest that RCE-4 exerted beneficially anti-cervical cancer effect on HeLa cells, mainly inhibiting PI3K/Akt/mTOR signaling pathway phosphorylation and NF-\u03baB activation, promoting HeLa cell apoptosis. Graphical abstract Anti-tumor effect of RCE-4 on HeLa cells."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Hubei Key Laboratory of Natural Products Research and Development, China Three Gorges University, 8, University Avenue, 443002, Yichang, Hubei, China."}], "LastName": "Bai", "ForeName": "Caihong", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Hubei Key Laboratory of Natural Products Research and Development, China Three Gorges University, 8, University Avenue, 443002, Yichang, Hubei, China."}], "LastName": "Yang", "ForeName": "Xiaojiao", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Hubei Key Laboratory of Natural Products Research and Development, China Three Gorges University, 8, University Avenue, 443002, Yichang, Hubei, China."}], "LastName": "Zou", "ForeName": "Kun", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Hubei Key Laboratory of Natural Products Research and Development, China Three Gorges University, 8, University Avenue, 443002, Yichang, Hubei, China. hehaibo252219@163.com."}, {"Identifier": [], "Affiliation": "Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang, Hubei, China. hehaibo252219@163.com."}], "LastName": "He", "ForeName": "Haibo", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Hubei Key Laboratory of Natural Products Research and Development, China Three Gorges University, 8, University Avenue, 443002, Yichang, Hubei, China."}], "LastName": "Wang", "ForeName": "Junzhi", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Hubei Key Laboratory of Natural Products Research and Development, China Three Gorges University, 8, University Avenue, 443002, Yichang, Hubei, China."}], "LastName": "Qin", "ForeName": "Huilin", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Hubei Key Laboratory of Natural Products Research and Development, China Three Gorges University, 8, University Avenue, 443002, Yichang, Hubei, China."}], "LastName": "Yu", "ForeName": "Xiaoqin", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Hubei Key Laboratory of Natural Products Research and Development, China Three Gorges University, 8, University Avenue, 443002, Yichang, Hubei, China."}], "LastName": "Liu", "ForeName": "Chengxiong", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Hubei Key Laboratory of Natural Products Research and Development, China Three Gorges University, 8, University Avenue, 443002, Yichang, Hubei, China."}], "LastName": "Zheng", "ForeName": "Juyan", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Hubei Key Laboratory of Natural Products Research and Development, China Three Gorges University, 8, University Avenue, 443002, Yichang, Hubei, China."}], "LastName": "Cheng", "ForeName": "Fan", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Hubei Key Laboratory of Natural Products Research and Development, China Three Gorges University, 8, University Avenue, 443002, Yichang, Hubei, China."}], "LastName": "Chen", "ForeName": "Jianfeng", "Initials": "J"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Naunyn Schmiedebergs Arch Pharmacol", "NlmUniqueID": "0326264", "ISSNLinking": "0028-1298"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Apoptosis Regulatory Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Cytokines"}, {"RegistryNumber": "0", "NameOfSubstance": "Inflammation Mediators"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-kappa B"}, {"RegistryNumber": "0", "NameOfSubstance": "RCE-4 compound"}, {"RegistryNumber": "0", "NameOfSubstance": "Saponins"}, {"RegistryNumber": "0", "NameOfSubstance": "Spirostans"}, {"RegistryNumber": "EC 1.1.1.27", "NameOfSubstance": "L-Lactate Dehydrogenase"}, {"RegistryNumber": "EC 2.7.1.1", "NameOfSubstance": "MTOR protein, human"}, {"RegistryNumber": "EC 2.7.1.137", "NameOfSubstance": "Phosphatidylinositol 3-Kinase"}, {"RegistryNumber": "EC 2.7.11.1", "NameOfSubstance": "Proto-Oncogene Proteins c-akt"}, {"RegistryNumber": "EC 2.7.11.1", "NameOfSubstance": "TOR Serine-Threonine Kinases"}], "MeshHeadingList": [{"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["metabolism"], "DescriptorName": "Apoptosis Regulatory Proteins"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cytokines"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": [], "DescriptorName": "Enzyme Activation"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "HeLa Cells"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Inflammation Mediators"}, {"QualifierName": [], "DescriptorName": "Inhibitory Concentration 50"}, {"QualifierName": ["metabolism"], "DescriptorName": "L-Lactate Dehydrogenase"}, {"QualifierName": ["chemistry"], "DescriptorName": "Liliaceae"}, {"QualifierName": [], "DescriptorName": "MCF-7 Cells"}, {"QualifierName": ["metabolism"], "DescriptorName": "NF-kappa B"}, {"QualifierName": ["metabolism"], "DescriptorName": "Phosphatidylinositol 3-Kinase"}, {"QualifierName": [], "DescriptorName": "Phosphorylation"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["metabolism"], "DescriptorName": "Proto-Oncogene Proteins c-akt"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Saponins"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Spirostans"}, {"QualifierName": ["metabolism"], "DescriptorName": "TOR Serine-Threonine Kinases"}, {"QualifierName": ["drug therapy", "enzymology", "pathology"], "DescriptorName": "Uterine Cervical Neoplasms"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Mol Cell Biochem. 2012 Apr;363(1-2):385-93", "ArticleIdList": ["22193459"]}, {"Citation": "Pharmacol Rep. 2014 Aug;66(4):677-85", "ArticleIdList": ["24948071"]}, {"Citation": "Biochim Biophys Acta. 2010 Oct-Dec;1799(10-12):775-87", "ArticleIdList": ["20493977"]}, {"Citation": "Med Oncol. 2015 Mar;32(3):72", "ArticleIdList": ["25694047"]}, {"Citation": "Int J Clin Exp Med. 2015 Sep 15;8(9):16926-33", "ArticleIdList": ["26629245"]}, {"Citation": "Nat Prod Res. 2013;27(2):85-92", "ArticleIdList": ["22304302"]}, {"Citation": "Cell Signal. 2010 Sep;22(9):1282-90", "ArticleIdList": ["20363318"]}, {"Citation": "J Pharm Pharmacol. 2014 Jun;66(6):844-54", "ArticleIdList": ["24392651"]}, {"Citation": "Fitoterapia. 2011 Oct;82(7):1093-101", "ArticleIdList": ["21787849"]}, {"Citation": "J Biol Chem. 2008 Sep 19;283(38):25900-12", "ArticleIdList": ["18515365"]}, {"Citation": "Nature. 2002 Dec 19-26;420(6917):860-7", "ArticleIdList": ["12490959"]}, {"Citation": "Expert Opin Ther Targets. 2010 Jan;14(1):45-55", "ArticleIdList": ["20001209"]}, {"Citation": "Tumour Biol. 2013 Aug;34(4):2433-40", "ArticleIdList": ["23595222"]}, {"Citation": "Cancer Res Treat. 2015 Apr;47(2):313-21", "ArticleIdList": ["25578058"]}, {"Citation": "Cancer Lett. 2008 Apr 18;262(2):190-200", "ArticleIdList": ["18222036"]}, {"Citation": "Phytother Res. 2014 Jul;28(7):1037-44", "ArticleIdList": ["25289403"]}, {"Citation": "Toxicol Appl Pharmacol. 2012 May 15;261(1):10-21", "ArticleIdList": ["22369883"]}, {"Citation": "Oncol Lett. 2015 Nov;10(5):2919-2924", "ArticleIdList": ["26722264"]}, {"Citation": "Pharmacol Ther. 2014 May;142(2):164-75", "ArticleIdList": ["24333502"]}, {"Citation": "Front Physiol. 2014 Dec 16;5:478", "ArticleIdList": ["25566081"]}, {"Citation": "Drug Des Devel Ther. 2015 Mar 16;9:1601-26", "ArticleIdList": ["25834400"]}, {"Citation": "Int J Mol Med. 2013 Jan;31(1):219-24", "ArticleIdList": ["23151600"]}, {"Citation": "Chem Pharm Bull (Tokyo). 2011;59(1):53-6", "ArticleIdList": ["21212547"]}, {"Citation": "Nat Rev Cancer. 2002 Apr;2(4):301-10", "ArticleIdList": ["12001991"]}, {"Citation": "Fitoterapia. 2014 Dec;99:292-9", "ArticleIdList": ["25454461"]}, {"Citation": "Cancer Epidemiol Biomarkers Prev. 2010 Aug;19(8):1954-9", "ArticleIdList": ["20647411"]}, {"Citation": "Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62", "ArticleIdList": ["17183360"]}, {"Citation": "Biosci Rep. 2012 Jun;32(3):323-32", "ArticleIdList": ["22390170"]}, {"Citation": "Anticancer Agents Med Chem. 2013 Sep;13(7):1002-13", "ArticleIdList": ["23272910"]}, {"Citation": "Nature. 1999 Sep 2;401(6748):82-5", "ArticleIdList": ["10485710"]}, {"Citation": "Am Soc Clin Oncol Educ Book. 2013;:null", "ArticleIdList": ["23714559"]}], "ReferenceList": []}], "History": [{"Year": "2015", "Month": "7", "Day": "27"}, {"Year": "2016", "Month": "2", "Day": "8"}, {"Year": "2016", "Month": "3", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "3", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "2", "Day": "22", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["26935715", "10.1007/s00210-016-1217-7", "10.1007/s00210-016-1217-7"]}}], "PubmedBookArticle": []}